High Hampton Holdings Corp Share Price Canadian Securities Exchange
Equities
CA42966X3094
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 563K 412K 34.35M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
Net cash position 2022 | 841K 616K 51.29M | Net cash position 2023 | 690K 505K 42.09M | EV / Sales 2023 | - |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
-8.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.53% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 26/23/26 |
Director of Finance/CFO | 54 | 19/23/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 54 | 19/23/19 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 26/23/26 |
Anderson Shannon
BRD | Director/Board Member | - | 19/23/19 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |